Alpha 1 Antitrypsin Deficiency & COPD
Alpha-1 antitrypsin deficiency is a genetic disorder that is passed on in families and affects the lungs, liver and skin. When this condition affects the lungs, it causes COPD. There is no cure, but treatment can help people with Alpha-1 antitrypsin deficiency manage their symptoms and live a better life. The preliminary symptoms are shortness of breath following mild activity, reduced ability to exercise, and wheezing. Other signs and symptoms include unintentional weight loss, recurring respiratory infections, fatigue, and rapid heartbeat upon standing. Affected individuals often develop emphysema, which is a lung disease caused by damage to the small air sacs in the lungs. Alpha-1 antitrypsin deficiency accounts for 1 to 2% of all cases of chronic obstructive pulmonary disease.
Related Conference of Alpha 1 Antitrypsin Deficiency & COPD
6th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
16th International Conference on Pulmonary & Respiratory Medicine
18th International Conference on Chronic Obstructive Pulmonary Disease
Alpha 1 Antitrypsin Deficiency & COPD Conference Speakers
Recommended Sessions
- Asthma
- Chronic Obstructive Pulmonary Disease
- Alpha 1 Antitrypsin Deficiency & COPD
- Cardiopulmonary Disorders
- Clinical management of severe acute respiratory infection
- COVID-19 Treatment and Recovery
- Covid19 Vaccine and Lung Immunopathology
- Cystic Fibrosis
- Depression and anxiety in COPD
- Diagnosis and Treatment of COPD
- Digital Health in Respiratory Care
- Effect of COVID-19 on Lungs
- Genetic risk factor of COPD
- Idiopathic Pulmonary Fibrosis
- Innate Immunity and Lung Fibrosis
- Investigational Drugs and Other Therapies in the treatment of Respiratory Disease
- Lung cancer
- Lung Cancer Diagnosis & Treatment
- Pathology and Clinical Management of COPD
- Pneumonia
- Pulmonary Rehabilitation
- Respiratory Diseases
- Severe Acute Respiratory Syndrome (SARS)
- Sleep apnea
- Tuberculosis
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- AI in Respiratory Care - COPD SUMMIT 2026 (Italy)
- Air Pollution & Tobacco Control - COPD SUMMIT 2026 (Italy)
- Asthma COPD Overlap (ACO) - COPD SUMMIT 2026 (Italy)
- Asthma: New Insights & Therapies - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Airway Techniques - COPD SUMMIT 2026 (Italy)
- Cardiopulmonary Disease - Tuberculosis-2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2026 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2026 (France)
- COPD & Cardiovascular Diseases - COPD SUMMIT 2026 (Italy)
- COPD Diagnosis & Guidelines - COPD SUMMIT 2026 (Italy)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis - COPD SUMMIT 2026 (Italy)
- COPD Pharmacotherapy - COPD SUMMIT 2026 (Italy)
- COPD Prevention & Self-Management - COPD SUMMIT 2026 (Italy)
- COPD: Advances & Management - COPD SUMMIT 2026 (Italy)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - COPD SUMMIT 2026 (Italy)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Drug-Resistant Tuberculosis: - Tuberculosis-2026 (France)
- Early Detection and Diagnosis - Tuberculosis-2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Epidemiology of TB Disease - Tuberculosis-2026 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2026 (France)
- Infection Control Measures - Tuberculosis-2026 (France)
- Integrated Healthcare Approach - Tuberculosis-2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Latent TB Infection and Active TB Disease - Tuberculosis-2026 (France)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Cancer: Diagnosis & Treatment - COPD SUMMIT 2026 (Italy)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2026 (France)
- Lung Fibrosis - COPD SUMMIT 2026 (Italy)
- Lung Function in Men with and without HIV - Tuberculosis-2026 (France)
- Lung Infection - Tuberculosis-2026 (France)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Multidrug-resistant TB - Tuberculosis-2026 (France)
- Mycobacterial Infections - Tuberculosis-2026 (France)
- Next-Gen COPD Treatments - COPD SUMMIT 2026 (Italy)
- Non-Invasive Ventilation (NIV) - COPD SUMMIT 2026 (Italy)
- Nutrition and Tuberculosis - Tuberculosis-2026 (France)
- One Health Approach to TB Control - Tuberculosis-2026 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2026 (France)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Respiratory Care - COPD SUMMIT 2026 (Italy)
- Pediatric Tuberculosis - Tuberculosis-2026 (France)
- Personalized Pulmonary Medicine - COPD SUMMIT 2026 (Italy)
- Pneumonia & Tuberculosis - COPD SUMMIT 2026 (Italy)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Preventive Therapy - Tuberculosis-2026 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2026 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2026 (France)
- Pulmonary Edema - Tuberculosis-2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2026 (Italy)
- Research and Innovation - Tuberculosis-2026 (France)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Apnea - COPD SUMMIT 2026 (Italy)
- TB Clinical Trials - Tuberculosis-2026 (France)
- TB Vaccines - Tuberculosis-2026 (France)
- TB-HIV Co-Infection: - Tuberculosis-2026 (France)
- TB-HIV Co-infections - Tuberculosis-2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
- Tuberculosis in Vulnerable Populations - Tuberculosis-2026 (France)
- Vaccination Programs: - Tuberculosis-2026 (France)

